OncoSec Medical Inc. , a company developing DNA-based intratumoral cancer immunotherapies, has appointed Mai H. Le, M.D. to the position of Chief Medical Officer. In this role, Dr.
from Content Keyword RSS http://ift.tt/XuiStH
via IFTTT
from Content Keyword RSS http://ift.tt/XuiStH
via IFTTT
No comments:
Post a Comment